We are live on
!
Find out more
Cellebrite
CLBT
CLBT
116 hedge funds and large institutions have $780M invested in Cellebrite in 2023 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 49 increasing their positions, 18 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
2,726% more call options, than puts
Call options by funds: $650K | Put options by funds: $23K
183% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 12
172% more repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 18
94% more capital invested
Capital invested by funds: $403M → $780M (+$377M)
23% more funds holding
Funds holding: 94 → 116 (+22)
17.05% more ownership
Funds ownership: 28.61% → 45.67% (+17%)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
Holders
116
Holders Change
+22
Holders Change %
+23.4%
% of All Funds
1.69%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.09%
New
34
Increased
49
Reduced
18
Closed
12
Calls
$650K
Puts
$23K
Net Calls
+$627K
Net Calls Change
+$135K
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$38M |
| 2 |
NTCM
Nine Ten Capital Management
Chicago,
Illinois
|
+$20.5M |
| 3 |
ACM
Ashford Capital Management
Wilmington,
Delaware
|
+$11.6M |
| 4 |
VC
Voss Capital
Houston,
Texas
|
+$9.63M |
| 5 |
Two Sigma Investments
New York
|
+$7.33M |
